Maria B D Resende

Learn More
OBJECTIVE To assess the evolution of motor function in patients with Duchenne muscular dystrophy (DMD) treated with steroids (prednisolone or deflazacort) through the Motor Function Measure (MFM), which evaluates three dimensions of motor performance (D1, D2, D3). METHODS Thirty-three patients with DMD (22 ambulant, 6 non-ambulant and 5 who lost the(More)
BACKGROUND Congenital muscular dystrophy is a clinically and genetically heterogeneous group of myopathies. Congenital muscular dystrophy related to lamin A/C is rare and characterized by early-onset hypotonia with axial muscle weakness typically presenting with a loss in motor acquisitions within the first year of life and a dropped-head phenotype. (More)
Abbreviations: ADC ϭ apparent diffusion coefficient Cho ϭ choline-containing compounds CMD ϭ congenital muscular dystrophy Cr ϭ creatine/phosphocreatine FWM ϭ frontal WM mI ϭ myo-inositol NAA ϭ N-acetylaspartate POWM ϭ parieto-occipital WM WM ϭ white matter Authors stated no financial relationship to disclose. 1 PURPOSE: To prospectively use hydrogen 1 (1(More)
  • 1